PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Verrotti A. Epilepsy Behav. Mar 2020; 104(Pt A): 106939 Pubmed [9333]
Verschraagen M. Pharmacol Res. Oct 1999; 40(4): 301-6 Pubmed [13093]
Verweij J. Oncology. Jul 1999; 57 Suppl 1: 9-15 Pubmed [10015]
Veselinović T. Psychopharmacology (Berl). May 2015; 232(9): 1607-17 Pubmed [4338]
Vesell ES. N Engl J Med. Dec 1970; 283(27): 1484-8 Pubmed [13389]
Vestal RE, Kornhauser DM, Hollifierld JW, Shand DG. Inhibition of propanolol metabolism by chlorpromazine. Clin pharmacol Ther (1979) 25, 19-25 [922]
Vestri et al. (2007) Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis. Neuropsychopharmacol 32:765-772 [2783]
Vethe NT. Tidsskr Nor Laegeforen. Oct 2011; 131(20): 2000-3 Pubmed [7434]
Vetrugno R. Mov Disord. Feb 2007; 22(3): 424-7 Pubmed [12251]
Vets E. Am J Health Syst Pharm. May 2009; 66(9): 838-42 Pubmed [8619]
Vetter PH, Proppe DG. Clozapine induced coma. J Nerv Ment Dis (1992) 180, 58-9 [1052]
Vevelstad M. Eur J Clin Pharmacol. Aug 2009; 65(8): 795-801 Pubmed [405]
vgl. auch Literatur zur Interaktion von Clozapin mit Benzodiazepinen [1963]
Viani F. Eur J Pediatr. Sep 1992; 151(9): 715 Pubmed [5991]
Vicente J. Clin Pharmacol Ther. Apr 2019; 105(4): 943-953 Pubmed, Volltext, DOI [8723]
Vickers AE. Drug Metab Dispos. Sep 1999; 27(9): 1029-38 Pubmed [213]
Vidal EI. J Am Geriatr Soc. Jan 2013; 61(1): 170-2 Pubmed [9921]
Vidal X. Drug Saf. Jan 2008; 31(2): 159-68 Pubmed [998]
Vidović B. J Med Food. Jan 2017; 20(1): 79-85 Pubmed [11740]
Vieira ML. Clin Pharmacol Ther. Apr 2012; 91(4): 700-8 Pubmed [6538]
Viejo Sacha MG. Ann Clin Psychiatry. Feb 2013; 25(1): 67-8 Pubmed [9948]
Vierke C. Eur Arch Psychiatry Clin Neurosci. Aug 2021; 271(5): 847-856 Pubmed [10810]
Vieta E. J Affect Disord. Aug 2008; 109(3): 251-63 Pubmed [3891]
Vieweg WV. Acta Psychiatr Scand. Oct 2005; 112(4): 318-22; author reply 322 Pubmed [9155]
Vieweg WV. Am J Med. Sep 2012; 125(9): 859-68 Pubmed [13117]
Vieweg WV. Drugs Aging. Jan 2009; 26(12): 997-1012 Pubmed [2631]
Vieweg WV. Ther Adv Infect Dis. Aug 2013; 1(4): 121-38 Pubmed, Volltext, DOI [5322]
Vigneault P. Eur J Pharmacol. Apr 2012; 681(1-3): 68-74 Pubmed [3968]
Vigneault P. J Cardiovasc Pharmacol. Jun 2011; 57(6): 690-5 Pubmed [2630]
Vihavainen T. J Neurochem. Nov 2008; 107(3): 844-54 Pubmed [4167]
Vijay Kumar K G. Indian J Psychol Med. Sep 2021; 43(5): 456-458 Pubmed [12617]
Vijayaraghavan S. Nat Commun. Jun 2017; 8: 15916 Pubmed, Volltext, Nature [7539]
Vikelis M. J Clin Med. Jul 2023; 12(13) Pubmed [13502]
Vila A. Scand J Infect Dis. Jan 2001; 33(10): 788-9 Pubmed [6438]
Villikka K. Br J Clin Pharmacol. May 1997; 43(5): 471-4 Pubmed, Volltext, DOI [6205]
Villikka K. Clin Pharmacol Ther. Apr 1999; 65(4): 377-81 Pubmed [6202]
Villikka K. Clin Pharmacol Ther. Dec 1997; 62(6): 629-34 Pubmed [6204]
Villikka K. Clin Pharmacol Ther. Dec 1999; 66(6): 589-93 Pubmed [781]
Villikka K. Clin Pharmacol Ther. Jan 1997; 61(1): 8-14 Pubmed [6257]
Villikka K. Pharmacol Toxicol. Sep 1998; 83(3): 135-8 Pubmed [11976]
Vinceneux P. Int J Clin Pharmacol Ther Toxicol. Mar 1986; 24(3): 153-8 Pubmed [3569]
Vincent FM. Ann Intern Med. Jul 1980; 93(1): 56-7 Pubmed [652]
Vincent J. Br J Clin Pharmacol. Nov 2000; 50(5): 455-63 Pubmed, Volltext, DOI [3815]
Vincent SH. Drug Metab Dispos. Apr 2007; 35(4): 533-8 Pubmed [4324]
Vinetti M. Clin Toxicol (Phila). Jul 2013; 51(6): 516-7 Pubmed [11158]
Viramontes TS. Consult Pharm. Mar 2016; 31(3): 139-50 Pubmed [4996]
Vispo E. Antivir Ther. Jan 2008; 13(3): 429-37 Pubmed [6703]
Vitali M. J Clin Psychopharmacol. Feb 2013; 33(1): 95-8 Pubmed [4874]
Vlase L. Eur J Drug Metab Pharmacokinet. Jan 2011; 35(3-4): 83-7 Pubmed [5846]
Vo KT. Clin Toxicol (Phila). Oct 2020; 58(10): 984-990 Pubmed [10707]
Vobra SB. Convulsions after enflurane in a schizophrenic patient receiving neuroleptics. Can J Anaesth (1994) 41, 420-2 [864]
Vogel M. Liver Transpl. Jul 2004; 10(7): 939-44 Pubmed [6488]
Vogelman et al. Neuropsychopharmacol 1999;20:480-490 [3135]
Vohora D. Drugs Today (Barc). Apr 2010; 46(4): 265-77 Pubmed [12323]
Voican CS. Am J Psychiatry. Apr 2014; 171(4): 404-15 Pubmed [3898]
Volans A. BMJ Case Rep. Jan 2013; 2013 Pubmed, Volltext, DOI [4033]
Voll ML. Pharm World Sci. Oct 2010; 32(5): 575-80 Pubmed [3671]
Vollmer-Haase J, Folkerts H. Aktuelle Neurologie. 24(4): 167-169 Pubmed [10702]
Volonté MA. Neurol Sci. Feb 2001; 22(1): 107-8 Pubmed [11601]
Volpi-Abadie J. Ochsner J. Jan 2013; 13(4): 533-40 Pubmed, Volltext [18]
von Moltke et al. J Pharm Sci. 1998 Oct;87(10):1184-9 [1234]
von Moltke LL. Biol Psychiatry. Feb 1997; 41(3): 377-80 Pubmed [3738]
von Moltke LL. Br J Clin Pharmacol. Jul 1994; 38(1): 23-31 Pubmed, Volltext [1331]
Von Moltke LL. Br J Clin Pharmacol. Jul 1999; 48(1): 89-97 Pubmed, Volltext, DOI [234]
von Moltke LL. Drug Metab Dispos. Aug 2001; 29(8): 1102-9 Pubmed [118]
von Moltke LL. J Clin Pharmacol. Dec 1994; 34(12): 1222-7 Pubmed [1881]
von Moltke LL. J Clin Pharmacol. Jan 2001; 41(1): 85-91 Pubmed [4636]
von Moltke LL. J Clin Pharmacol. Sep 1996; 36(9): 783-91 Pubmed [1874]
von Moltke LL. J Clin Psychopharmacol. Apr 1996; 16(2): 104-12 Pubmed [5884]
von Moltke LL. J Clin Psychopharmacol. Aug 1998; 18(4): 338-41 Pubmed [8309]
von Moltke LL. J Pharm Pharmacol. Sep 1998; 50(9): 997-1004 Pubmed [4503]
von Moltke LL. J Pharm Sci. Oct 1998; 87(10): 1184-9 Pubmed [4989]
von Moltke LL. J Pharmacol Exp Ther. Mar 1994; 268(3): 1278-83 Pubmed [377]
von Richter O. Clin Pharmacokinet. Jan 2007; 46(7): 613-22 Pubmed [3249]
von Rosensteil NA. Drug Saf. Aug 1995; 13(2): 105-22 Pubmed [5321]
von Rosenstiel P. Neurotherapeutics. Jan 2007; 4(1): 84-7 Pubmed [330]
Voorman RL. Drug Metab Dispos. Jan 2001; 29(1): 41-7 Pubmed [4471]
Vorspan F. Am J Addict. Sep 2010; 19(5): 458-9 Pubmed [3220]
Vos CF. Pharmacotherapy. Jun 2024; 44(6): 480-484 Pubmed [13858]
Vosse-Matagne G. Acta Gastroenterol Belg. Jul 1975; 38(7-8): 249-59 Pubmed [6106]
Vourvahis M. Clin Pharmacol Drug Dev. May 2014; 3(3): 202-6 Pubmed [6871]
Vrobel I. Eur J Pharm Sci. Jun 2017; 104: 335-343 Pubmed [10108]
Vrzal R. Toxicol Lett. Mar 2010; 193(2): 183-8 Pubmed [12092]
Vuurman EF. Eur J Clin Pharmacol. Jan 1994; 47(3): 253-9 Pubmed [9133]
Waade RB. Br J Clin Pharmacol. May 2021; 87(5): 2228-2235 Pubmed [12653]
Waade RB. Ther Drug Monit. Apr 2009; 31(2): 233-8 Pubmed [45]
Wada M. Biomed Chromatogr. Jun 2007; 21(6): 616-20 Pubmed [9990]
Wade A, Buchan P, Mant T, et al. Cephalalgia. Jan 2001; 21(4): 427 Pubmed [12839]
Wade AG. Psychol Med. Oct 2011; 41(10): 2089-97 Pubmed [7530]
Wadhani N. J Cardiovasc Pharmacol Ther. Sep 2006; 11(3): 184-90 Pubmed [3723]
Wagg A. Age Ageing. Jul 2017; 46(4): 620-626 Pubmed [10213]
Wagner E. J Psychopharmacol. Apr 2019; 33(4): 423-435 Pubmed [11795]
Wagner F, Kalusche D, Trenk D, Jähnchen E, Roskamm H. Drug interaction between propafenine and metoprolol Br J Clin Pharmacol. 1987 Aug;24(2):213–220 [2979]
Wagner J. J Neurol. Jul 2009; 256(7): 1182-3 Pubmed [3735]
Wagner J. Pediatrics. May 2015; 135(5): e1333-6 Pubmed [7079]
Wagner ML. Am J Hosp Pharm. Jul 1994; 51(13): 1657-66 Pubmed [9245]
Wagner ML. Clin Pharmacol Ther. May 1993; 53(5): 536-43 Pubmed [9495]
Wagner, Vause. Clin Pharmacokinet (1995) 29 (Suppl 1), 26-32 [1496]
Wagstaff AJ. CNS Drugs. Jan 2001; 15(3): 231-59 Pubmed [10828]
Wahawisan J. Ann Pharmacother. Jun 2011; 45(6): e34 Pubmed [3313]